Loading
Resverlogix Corp. Stock: price and insider trades · Canada
Resverlogix Corp.: what insiders have been doing
Resverlogix Corp. belongs to the Health Care sector. Filings by its managers are published through SEDI. Between 24 October 2025 and 24 October 2026, 5 insiders published 9 filings.
Not one of the filings records a straightforward purchase or sale on the market. Such operations are usually part of compensation schedules, which makes them a weaker signal than an open-market trade.
With 9 filings in twelve months, the company is quieter than the median of 14 filings across the 2,734 companies we follow on the same exchange. Looking back to 2016, when coverage begins, insiders filed 11 purchases and 38 sales.
Over the last twelve months, not one insider purchase of Resverlogix Corp. stock was filed. Between a trade and the moment it shows up on SEDI, the median delay is 3 days. That lag is the time during which only the insider knows about the trade.
Source: insider filings from SEDI. Past trades are no guide to future returns.
Insider Decl.
229
Thresholds
n/a
Buy Volume
€127,692
11 ops. · all time
Sell Volume
€142,168
38 ops. · all time
Who traded when
BuySaleAaron Bradley Cann5 sales
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Financial data
as of FY 2025FY ended December 2025 · cache
CA$0.09
Analyst consensus
Income statement
EBITDA-CA$3.1M
Net income-CA$7.8M0.0% margin
Valuation
Beta1.06
Balance sheet & cash
Market capCA$29.3M
Total debtCA$20.8M
Free Cash Flow-CA$4.4M
Profitability & ownership
ROA-40.3%
% insiders26.4%
% institutions0.0%
Last declaration on 9 July 2026
Declarations229 total
500,000 sharesRestricted Share Units (RSU's)TSXSEDI:4749803
350,000 sharesRestricted Share Units (RSU's)TSXSEDI:4749802
350,000 sharesRestricted Share Units (RSU's)TSXSEDI:4749799
216,666 sharesCommon SharesTSXSEDI:4664955
216,666 sharesCommon SharesTSXSEDI:4664956
100,000 sharesCommon SharesTSXSEDI:4659122
1,054,286 sharesUnits Deferred Share UnitsTSXSEDI:4634748
597,857 sharesUnits Deferred Share UnitsTSXSEDI:4634752
837,143 sharesUnits Deferred Share UnitsTSXSEDI:4634750
200,000 sharesCommon SharesTSXSEDI:4527204
200,000 shares@ CA$0.04514.2% of flowCommon SharesTSXSEDI:4527206
300,000 sharesCommon SharesTSXSEDI:4502454
300,000 sharesCommon SharesTSXSEDI:4502455
50,000 sharesCommon SharesTSXSEDI:4470782
200,000 sharesCommon SharesTSXSEDI:4406214
26,000 shares@ CA$0.060.9% of flowCommon SharesTSXSEDI:4406216
25,000 shares@ CA$0.060.9% of flowCommon SharesTSXSEDI:4406219
73,000 shares@ CA$0.062.6% of flowCommon SharesTSXSEDI:4406217
1,000 shares@ CA$0.060.0% of flowCommon SharesTSXSEDI:4406215
100,000 sharesCommon SharesTSXSEDI:4365803
150,000 sharesCommon SharesTSXSEDI:4365802
50,000 sharesCommon SharesTSXSEDI:4357251
175,000 sharesCommon SharesTSXSEDI:4357667
150,000 sharesCommon SharesTSXSEDI:4323349
150,000 sharesCommon SharesTSXSEDI:4305129
25 of 229 declarations
About Resverlogix Corp.
Resverlogix Corp. is a biopharmaceutical company focused on developing treatments for cardiovascular and metabolic diseases. It is listed on the XTSE.
